📰 Nasdaq Envb News
Nasdaq Envb News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Envb. Real-time updates on events, politics, business and more.
February 2, 2024
HC Wainwright reissued their buy rating on shares of Enveric Biosciences (NASDAQ:ENVB – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $10.00 target price on the stock. HC Wainwright also issued estimates for Enveric Biosciences’ Q4 2023 earnings at ($1.50) EPS, FY2023 earnings at ($8.10) […]
January 28, 2024
AdvisorShares Investments LLC raised its holdings in Enveric Biosciences, Inc. (NASDAQ:ENVB – Free Report) by 46.2% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 146,833 shares of the company’s stock after acquiring an additional 46,404 shares during the quarter. AdvisorShares Investments LLC owned approximately […]
January 28, 2024
AdvisorShares Investments LLC raised its stake in shares of Enveric Biosciences, Inc. (NASDAQ:ENVB – Free Report) by 46.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,833 shares of the company’s stock after acquiring an additional 46,404 shares during […]
December 21, 2023
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report)’s share price fell 1% during trading on Wednesday . The company traded as low as $1.34 and last traded at $1.36. 18,133 shares were traded during mid-day trading, a decline of 98% from the average session volume of 953,973 shares. The stock had previously closed at $1.37. […]
October 15, 2023
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 10,900 shares, a decrease of 55.0% from the September 15th total of 24,200 shares. Currently, 0.6% of the company’s shares are sold short. Based on an […]
August 27, 2023
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) saw a large growth in short interest in the month of August. As of August 15th, there was short interest totalling 76,600 shares, a growth of 86.4% from the July 31st total of 41,100 shares. Based on an average trading volume of 1,410,000 shares, the days-to-cover ratio […]
August 13, 2023
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 41,100 shares, an increase of 95.7% from the July 15th total of 21,000 shares. Currently, 2.2% of the company’s stock are sold short. […]
April 30, 2023
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Rating) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 22,500 shares, a growth of 39.8% from the March 31st total of 16,100 shares. Approximately 1.2% of the company’s stock are short sold. Based on an average daily volume of […]
March 13, 2022
Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Rating) was the target of a large decrease in short interest in February. As of February 28th, there was short interest totalling 322,700 shares, a decrease of 67.6% from the February 13th total of 996,300 shares. Based on an average trading volume of 2,170,000 shares, the days-to-cover ratio is […]